Cargando…

Thimerosal-containing Hepatitis B Vaccine Exposure is Highly Associated with Childhood Obesity: A Case-control Study Using the Vaccine Safety Datalink

BACKGROUND: Obesity among children and adolescents in the United States has tripled since 1980, and has become a major public health concern. AIMS: The purpose of this study was to evaluate the potential relationship between exposure to organic mercury from Thimerosal-containing hepatitis B vaccines...

Descripción completa

Detalles Bibliográficos
Autores principales: Geier, David A., Kern, Janet K., Homme, Kristin G., Sykes, Lisa K., Geier, Mark R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4982359/
https://www.ncbi.nlm.nih.gov/pubmed/27583238
http://dx.doi.org/10.4103/1947-2714.187148
_version_ 1782447770958823424
author Geier, David A.
Kern, Janet K.
Homme, Kristin G.
Sykes, Lisa K.
Geier, Mark R.
author_facet Geier, David A.
Kern, Janet K.
Homme, Kristin G.
Sykes, Lisa K.
Geier, Mark R.
author_sort Geier, David A.
collection PubMed
description BACKGROUND: Obesity among children and adolescents in the United States has tripled since 1980, and has become a major public health concern. AIMS: The purpose of this study was to evaluate the potential relationship between exposure to organic mercury from Thimerosal-containing hepatitis B vaccines and the children's subsequent risk of an obesity diagnosis. MATERIALS AND METHODS: A hypothesis-testing, case-control study was undertaken to evaluate exposure to organic mercury from Thimerosal-containing hepatitis B vaccines, which were administered at specific intervals in the first 6 months of life, among cases diagnosed with childhood obesity and controls by examining automated medical records for children born from 1991 to 2000 who were continuously enrolled in the Vaccine Safety Datalink database. RESULTS: This study found highly significant associations as follows. Cases diagnosed with obesity were significantly (P < 0.00001) more likely to have received greater exposure to organic mercury from Thimerosal-containing hepatitis B vaccines administered within the first month of life (odds ratio (OR) =1.511), first 2 months of life (OR = 1.486), and first 6 months of life (OR = 3.795) than the controls. Similar outcomes were observed when the overall data were separated by gender. In a dose-response manner, cases diagnosed with obesity were significantly more likely than controls to have received greater exposure to organic mercury from Thimerosal-containing hepatitis B vaccines, which were administered within the first 6 months of life (OR = 1.0375 per μg of mercury, P < 0.00001). CONCLUSIONS: In a dose-response manner, the present study associates an increased organic mercury exposure from Thimerosal-containing hepatitis B vaccines with an increased risk of obesity diagnosis, and suggests that Thimerosal is an obesogen. The results are biologically plausible and future studies are needed to examine this phenomenon.
format Online
Article
Text
id pubmed-4982359
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-49823592016-08-31 Thimerosal-containing Hepatitis B Vaccine Exposure is Highly Associated with Childhood Obesity: A Case-control Study Using the Vaccine Safety Datalink Geier, David A. Kern, Janet K. Homme, Kristin G. Sykes, Lisa K. Geier, Mark R. N Am J Med Sci Original Article BACKGROUND: Obesity among children and adolescents in the United States has tripled since 1980, and has become a major public health concern. AIMS: The purpose of this study was to evaluate the potential relationship between exposure to organic mercury from Thimerosal-containing hepatitis B vaccines and the children's subsequent risk of an obesity diagnosis. MATERIALS AND METHODS: A hypothesis-testing, case-control study was undertaken to evaluate exposure to organic mercury from Thimerosal-containing hepatitis B vaccines, which were administered at specific intervals in the first 6 months of life, among cases diagnosed with childhood obesity and controls by examining automated medical records for children born from 1991 to 2000 who were continuously enrolled in the Vaccine Safety Datalink database. RESULTS: This study found highly significant associations as follows. Cases diagnosed with obesity were significantly (P < 0.00001) more likely to have received greater exposure to organic mercury from Thimerosal-containing hepatitis B vaccines administered within the first month of life (odds ratio (OR) =1.511), first 2 months of life (OR = 1.486), and first 6 months of life (OR = 3.795) than the controls. Similar outcomes were observed when the overall data were separated by gender. In a dose-response manner, cases diagnosed with obesity were significantly more likely than controls to have received greater exposure to organic mercury from Thimerosal-containing hepatitis B vaccines, which were administered within the first 6 months of life (OR = 1.0375 per μg of mercury, P < 0.00001). CONCLUSIONS: In a dose-response manner, the present study associates an increased organic mercury exposure from Thimerosal-containing hepatitis B vaccines with an increased risk of obesity diagnosis, and suggests that Thimerosal is an obesogen. The results are biologically plausible and future studies are needed to examine this phenomenon. Medknow Publications & Media Pvt Ltd 2016-07 /pmc/articles/PMC4982359/ /pubmed/27583238 http://dx.doi.org/10.4103/1947-2714.187148 Text en Copyright: © 2016 North American Journal of Medical Sciences http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Original Article
Geier, David A.
Kern, Janet K.
Homme, Kristin G.
Sykes, Lisa K.
Geier, Mark R.
Thimerosal-containing Hepatitis B Vaccine Exposure is Highly Associated with Childhood Obesity: A Case-control Study Using the Vaccine Safety Datalink
title Thimerosal-containing Hepatitis B Vaccine Exposure is Highly Associated with Childhood Obesity: A Case-control Study Using the Vaccine Safety Datalink
title_full Thimerosal-containing Hepatitis B Vaccine Exposure is Highly Associated with Childhood Obesity: A Case-control Study Using the Vaccine Safety Datalink
title_fullStr Thimerosal-containing Hepatitis B Vaccine Exposure is Highly Associated with Childhood Obesity: A Case-control Study Using the Vaccine Safety Datalink
title_full_unstemmed Thimerosal-containing Hepatitis B Vaccine Exposure is Highly Associated with Childhood Obesity: A Case-control Study Using the Vaccine Safety Datalink
title_short Thimerosal-containing Hepatitis B Vaccine Exposure is Highly Associated with Childhood Obesity: A Case-control Study Using the Vaccine Safety Datalink
title_sort thimerosal-containing hepatitis b vaccine exposure is highly associated with childhood obesity: a case-control study using the vaccine safety datalink
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4982359/
https://www.ncbi.nlm.nih.gov/pubmed/27583238
http://dx.doi.org/10.4103/1947-2714.187148
work_keys_str_mv AT geierdavida thimerosalcontaininghepatitisbvaccineexposureishighlyassociatedwithchildhoodobesityacasecontrolstudyusingthevaccinesafetydatalink
AT kernjanetk thimerosalcontaininghepatitisbvaccineexposureishighlyassociatedwithchildhoodobesityacasecontrolstudyusingthevaccinesafetydatalink
AT hommekristing thimerosalcontaininghepatitisbvaccineexposureishighlyassociatedwithchildhoodobesityacasecontrolstudyusingthevaccinesafetydatalink
AT sykeslisak thimerosalcontaininghepatitisbvaccineexposureishighlyassociatedwithchildhoodobesityacasecontrolstudyusingthevaccinesafetydatalink
AT geiermarkr thimerosalcontaininghepatitisbvaccineexposureishighlyassociatedwithchildhoodobesityacasecontrolstudyusingthevaccinesafetydatalink